Moderna's COVID Vaccine Produces Strong Immune Response In Young Kids “Children receiving both shots in Moderna’s trial had antibody levels 1.5 times higher than those in young adults after one month.”
, the pharmaceutical company announced Monday. The news is most likely a relief for parents who have been waiting for more research surrounding the safety of the vaccine in younger children.
Children receiving both jabs in Moderna’s trial had antibody levels 1.5 times higher than those in young adults after one month, the company said. According to , the Moderna study tested the vaccine in 4,753 children over an eight-week period. Each shot contained 50 micrograms of vaccine, which amounts to half of the adult dose.It’s important to point out here that Moderna did not release the entire dataset, nor were the findings published in a peer-reviewed journal. The results of the company’s research were announced just one day before a panel of experts with the Food and Drug Administration will review vaccine data for children aged 5 to 11.
Moderna says a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds. The company says vaccinated kids developed virus-fighting antibodies similar to levels that young adults produce after full-strength shots.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Moderna Data Shows Covid-19 Vaccine Produced Strong Immune Response in 6- to 11-Year-OldsModerna said it would submit the results from an interim study to health regulators in the U.S., Europe and elsewhere in seeking authorization for 6- to 11-year-olds.
続きを読む »
Moderna says its Covid-19 vaccine was well-tolerated and generated robust immune response in children ages 6 to 11Interim results of a Phase 2/3 trial showed Moderna's Covid-19 vaccine was well-tolerated and generated a robust immune response in children ages 6 to 11, the company said Monday.
続きを読む »
Moderna says kids 6 to 11 show strong immune response to vaccineThe children studied developed virus-fighting antibodies similar to the levels vaccinated adults received from a full dose.
続きを読む »
Moderna says its Covid vaccine has strong results in children ages 6 to 11Data from an interim study showed two 50 microgram doses of the vaccine, half the strength of the doses used in the vaccine given to adults, generated virus-neutralizing antibodies in children.
続きを読む »
Moderna says its COVID-19 vaccine is protective, safe in kids 6 to 11Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and safety was comparable to what was previously seen in clinical trials of adolescents and adults.
続きを読む »